author-photo

Naveen Karkada

GlaxoSmithKline

21

Papers

230

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Inference under covariate-adaptive randomization: A simulation study.

2021 Statistical Methods in Medical Research
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.

2020 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (1)
Long‐term persistence of immune response to the AS04‐adjuvanted HPV‐16/18 vaccine in Chinese girls aged 9‐17 years: Results from an 8‐9‐year follow‐up phase III open‐label study

2020 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children.

2020 Infectious Diseases and Therapy
Show All
- Source
- Cite
- Save
Citations (1)
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

2020 EClinicalMedicine
Show All
- Source
- Cite
- Save
Citations (2)
Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus–16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial

2019 Pediatric Infectious Disease Journal
Show All
- Source
- Cite
- Save
Citations (3)
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years.

2019 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (13)
Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials

2019 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (12)
Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types

2019 Expert Review of Vaccines
Show All
- Source
- Cite
- Save
Citations (11)
Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial

2019 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (8)